OnKure aims for $60M in new funding round

BOULDER — Biopharmaceutical company OnKure Inc. has raised nearly $54 million of a $60 million funding round, according to documents filed with the U.S. Securities and Exchange Commission.

In a statement emailed to BizWest on Monday, a company spokeswoman said that, “at this time, the company cannot provide any additional comments or information outside of the filing.”

OnKure, headquartered at 6707 Winchester Circle in the Gunbarrel neighborhood of northeast Boulder, raised $3.26 million in a Series A-1 investment in 2020 and  $55 million in a round of Series B fundraising in 2021. Its therapeutics division expanded its workspace with…